Oman Vaccine Study Uses Bioject Technology

Tag it:

In Oman, a needle free system is being used in an inactivated polio vaccine, or study. The Health Ministry's Department of Communicable Disease and Control, in Oman, with the World Health Organization, is conducting the study.
The study is to determine whether or not three fractional doses of inactivated polio vaccine given intradermally are as effective as one full dose given intramuscularly.

Over a seven-month period, 400 newborns will have the study preformed on them. An evaluation will also be carried out to see whether or not needle-free jet injectors will replace the needle and syringe.

"Intradermal delivery of reduced doses of IPV could help countries with limited resources to use this vaccine, said Dr Roland Sutter of W.H.O. He adds, "Intradermal delivery is difficult to preform reliably with needles and syringes, and we feel that
needle-free delivery systems such as the B2000 would be a safer, easier and more reliable method for intradermal delivery of IPV."

Bioject is the developer of needle-free drug delivery systems, based in Portland.

Tag it:

Tags:

Click to add your tags...,

or Close

Comments (0) >>

Write comment

You must be logged in to a comment. Please register if you do not have an account yet.